APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 4%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific, have a share over 57 percent. In terms of Production, Cellulose and Derivatives is the largest segment, with a share over 51%. And in terms of Application, the largest application is Solid Preparation Excipients, followed by Semi-Solid Preparation Excipients, Liquid Preparation Excipients, etc.

This report provides an overview of the global Pharmaceutical Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

Read the full market overview

The report also presents Pharmaceutical Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Excipients Segment by Company

DuPont (FMC)

JRS Pharma

BASF

Lubrizol

Ashland

Croda International

Roquette

Shin-Etsu

Evonik

Associated British Foods

Hnerkang

Anhui Sunhere Pharmaceutical Excipients

Chase Sun

Pharmaceutical Excipients Segment by Type

Cellulose and Derivatives

Starch and Derivatives

Inorganic Salts

Medicinal Sucrose

Other

Pharmaceutical Excipients Segment by Application

Formulation Stability Excipients

Solid Preparation Excipients

Semi-Solid Preparation Excipients

Liquid Preparation Excipients

Other

Pharmaceutical Excipients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Excipients Industry Trends Table 2. Pharmaceutical Excipients Industry Drivers Table 3. Pharmaceutical Excipients Industry Opportunities and Challenges Table 4. Pharmaceutical Excipients Industry Restraints Table 5. Global Pharmaceutical Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Excipients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical Excipients Sales by Manufacturers (K Ton) & (2021-2026) Table 8. Global Pharmaceutical Excipients Sales Market Share by Manufacturers Table 9. Global Pharmaceutical Excipients Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical Excipients Manufacturers, Product Type & Application Table 13. Global Pharmaceutical Excipients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cellulose and Derivatives Table 17. Major Manufacturers of Starch and Derivatives Table 18. Major Manufacturers of Inorganic Salts Table 19. Major Manufacturers of Medicinal Sucrose Table 20. Major Manufacturers of Other Table 21. Global Pharmaceutical Excipients Sales by Type 2021 VS 2025 VS 2032 (K Ton) Table 22. Global Pharmaceutical Excipients Sales by Type (2021-2026) & (K Ton) Table 23. Global Pharmaceutical Excipients Sales by Type (2027-2032) & (K Ton) Table 24. Global Pharmaceutical Excipients Sales Market Share by Type (2021-2026) Table 25. Global Pharmaceutical Excipients Sales Market Share by Type (2027-2032) Table 26. Global Pharmaceutical Excipients Revenue by Type 2021 VS 2025 VS 2032 (K Ton) Table 27. Global Pharmaceutical Excipients Revenue by Type (2021-2026) & (K Ton) Table 28. Global Pharmaceutical Excipients Revenue by Type (2027-2032) & (K Ton) Table 29. Global Pharmaceutical Excipients Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Excipients Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Formulation Stability Excipients Table 32. Major Manufacturers of Solid Preparation Excipients Table 33. Major Manufacturers of Semi-Solid Preparation Excipients Table 34. Major Manufacturers of Liquid Preparation Excipients Table 35. Major Manufacturers of Other Table 36. Global Pharmaceutical Excipients Sales by Application 2021 VS 2025 VS 2032 (K Ton) Table 37. Global Pharmaceutical Excipients Sales by Application (2021-2026) & (K Ton) Table 38. Global Pharmaceutical Excipients Sales by Application (2027-2032) & (K Ton) Table 39. Global Pharmaceutical Excipients Sales Market Share by Application (2021-2026) Table 40. Global Pharmaceutical Excipients Sales Market Share by Application (2027-2032) Table 41. Global Pharmaceutical Excipients Revenue by Application 2021 VS 2025 VS 2032 (K Ton) Table 42. Global Pharmaceutical Excipients Revenue by Application (2021-2026) & (K Ton) Table 43. Global Pharmaceutical Excipients Revenue by Application (2027-2032) & (K Ton) Table 44. Global Pharmaceutical Excipients Revenue Market Share by Application (2021-2026) Table 45. Global Pharmaceutical Excipients Revenue Market Share by Application (2027-2032) Table 46. Global Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (K Ton) Table 47. Global Pharmaceutical Excipients Sales by Region (2021-2026) & (K Ton) Table 48. Global Pharmaceutical Excipients Sales Market Share by Region (2021-2026) Table 49. Global Pharmaceutical Excipients Sales Forecasted by Region (2027-2032) & (K Ton) Table 50. Global Pharmaceutical Excipients Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Ton) Table 52. North America Pharmaceutical Excipients Sales by Country (2021-2026) & (K Ton) Table 53. North America Pharmaceutical Excipients Sales by Country (2027-2032) & (K Ton) Table 54. Europe Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Ton) Table 55. Europe Pharmaceutical Excipients Sales by Country (2021-2026) & (K Ton) Table 56. Europe Pharmaceutical Excipients Sales by Country (2027-2032) & (K Ton) Table 57. Asia Pacific Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Ton) Table 58. Asia Pacific Pharmaceutical Excipients Sales by Country (2021-2026) & (K Ton) Table 59. Asia Pacific Pharmaceutical Excipients Sales by Country (2027-2032) & (K Ton) Table 60. South America, Middle East and Africa Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Ton) Table 61. South America, Middle East and Africa Pharmaceutical Excipients Sales by Country (2021-2026) & (K Ton) Table 62. South America, Middle East and Africa Pharmaceutical Excipients Sales by Country (2027-2032) & (K Ton) Table 63. Global Pharmaceutical Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Pharmaceutical Excipients Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Pharmaceutical Excipients Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Pharmaceutical Excipients Revenue Market Share by Region (2021-2026) Table 67. Global Pharmaceutical Excipients Revenue Market Share by Region (2027-2032) Table 68. DuPont (FMC) Company Information Table 69. DuPont (FMC) Business Overview Table 70. DuPont (FMC) Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. DuPont (FMC) Pharmaceutical Excipients Product Portfolio Table 72. DuPont (FMC) Recent Development Table 73. JRS Pharma Company Information Table 74. JRS Pharma Business Overview Table 75. JRS Pharma Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. JRS Pharma Pharmaceutical Excipients Product Portfolio Table 77. JRS Pharma Recent Development Table 78. BASF Company Information Table 79. BASF Business Overview Table 80. BASF Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BASF Pharmaceutical Excipients Product Portfolio Table 82. BASF Recent Development Table 83. Lubrizol Company Information Table 84. Lubrizol Business Overview Table 85. Lubrizol Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Lubrizol Pharmaceutical Excipients Product Portfolio Table 87. Lubrizol Recent Development Table 88. Ashland Company Information Table 89. Ashland Business Overview Table 90. Ashland Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ashland Pharmaceutical Excipients Product Portfolio Table 92. Ashland Recent Development Table 93. Croda International Company Information Table 94. Croda International Business Overview Table 95. Croda International Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Croda International Pharmaceutical Excipients Product Portfolio Table 97. Croda International Recent Development Table 98. Roquette Company Information Table 99. Roquette Business Overview Table 100. Roquette Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Roquette Pharmaceutical Excipients Product Portfolio Table 102. Roquette Recent Development Table 103. Shin-Etsu Company Information Table 104. Shin-Etsu Business Overview Table 105. Shin-Etsu Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shin-Etsu Pharmaceutical Excipients Product Portfolio Table 107. Shin-Etsu Recent Development Table 108. Evonik Company Information Table 109. Evonik Business Overview Table 110. Evonik Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Evonik Pharmaceutical Excipients Product Portfolio Table 112. Evonik Recent Development Table 113. Associated British Foods Company Information Table 114. Associated British Foods Business Overview Table 115. Associated British Foods Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Associated British Foods Pharmaceutical Excipients Product Portfolio Table 117. Associated British Foods Recent Development Table 118. Hnerkang Company Information Table 119. Hnerkang Business Overview Table 120. Hnerkang Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hnerkang Pharmaceutical Excipients Product Portfolio Table 122. Hnerkang Recent Development Table 123. Anhui Sunhere Pharmaceutical Excipients Company Information Table 124. Anhui Sunhere Pharmaceutical Excipients Business Overview Table 125. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolio Table 127. Anhui Sunhere Pharmaceutical Excipients Recent Development Table 128. Chase Sun Company Information Table 129. Chase Sun Business Overview Table 130. Chase Sun Pharmaceutical Excipients Sales (K Ton), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Chase Sun Pharmaceutical Excipients Product Portfolio Table 132. Chase Sun Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Pharmaceutical Excipients Distributors List Table 136. Pharmaceutical Excipients Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients Product Image Figure 2. Global Pharmaceutical Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipients Sales (2021-2032) & (K Ton) Figure 5. Global Pharmaceutical Excipients Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceutical Excipients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cellulose and Derivatives Image Figure 9. Starch and Derivatives Image Figure 10. Inorganic Salts Image Figure 11. Medicinal Sucrose Image Figure 12. Other Image Figure 13. Global Pharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032) & (K Ton) Figure 14. Global Pharmaceutical Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Excipients Sales Market Share by Type (2021-2032) Figure 16. Global Pharmaceutical Excipients Revenue by Type (2021 VS 2025 VS 2032) & (K Ton) Figure 17. Global Pharmaceutical Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Excipients Revenue Market Share by Type (2021-2032) Figure 19. Formulation Stability Excipients Image Figure 20. Solid Preparation Excipients Image Figure 21. Semi-Solid Preparation Excipients Image Figure 22. Liquid Preparation Excipients Image Figure 23. Other Image Figure 24. Global Pharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032) & (K Ton) Figure 25. Global Pharmaceutical Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pharmaceutical Excipients Sales Market Share by Application (2021-2032) Figure 27. Global Pharmaceutical Excipients Revenue by Application (2021 VS 2025 VS 2032) & (K Ton) Figure 28. Global Pharmaceutical Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Pharmaceutical Excipients Revenue Market Share by Application (2021-2032) Figure 30. North America Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 31. North America Pharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 32. U.S. Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 33. Canada Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 34. Mexico Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 35. Europe Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 36. Europe Pharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 37. Germany Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 38. France Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 39. U.K. Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 40. Italy Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 41. Netherlands Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 42. Asia Pacific Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 43. Asia Pacific Pharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 44. China Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 45. Japan Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 46. South Korea Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 47. Southeast Asia Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 48. India Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 49. Australia Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 50. South America, Middle East and Africa Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 51. South America, Middle East and Africa Pharmaceutical Excipients Sales Market Share by Country (2021-2032) Figure 52. Brazil Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 53. South Africa Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 54. Saudi Arabia Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 55. Turkey Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 56. Argentina Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 57. UAE Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 58. Egypt Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 59. Chile Pharmaceutical Excipients Sales and Growth Rate (2021-2032) & (K Ton) Figure 60. Global Pharmaceutical Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Pharmaceutical Excipients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Pharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 63. North America Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Pharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 65. Europe Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Pharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Pharmaceutical Excipients Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Pharmaceutical Excipients Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Pharmaceutical Excipients Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cellulose and Derivatives
  • Starch and Derivatives
  • Inorganic Salts
  • Medicinal Sucrose
  • Other
Applications
  • Formulation Stability Excipients
  • Solid Preparation Excipients
  • Semi-Solid Preparation Excipients
  • Liquid Preparation Excipients
  • Other
Companies covered
  • DuPont (FMC)
  • JRS Pharma
  • BASF
  • Lubrizol
  • Ashland
  • Croda International
  • Roquette
  • Shin-Etsu
  • Evonik
  • Associated British Foods
  • Hnerkang
  • Anhui Sunhere Pharmaceutical Excipients
  • Chase Sun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Excipients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceutical Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceutical Excipients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceutical Excipients Market Dynamics
  1. 2.1 Pharmaceutical Excipients Industry Trends
  2. 2.2 Pharmaceutical Excipients Industry Drivers
  3. 2.3 Pharmaceutical Excipients Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients Industry Restraints
3 Pharmaceutical Excipients Market by Manufacturers
  1. 3.1 Global Pharmaceutical Excipients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical Excipients Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Excipients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Excipients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical Excipients Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical Excipients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Excipients Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Excipients Market by Type
  1. 4.1 Pharmaceutical Excipients Type Introduction
  2. 4.1.1 Cellulose and Derivatives
  3. 4.1.2 Starch and Derivatives
  4. 4.1.3 Inorganic Salts
  5. 4.1.4 Medicinal Sucrose
  6. 4.1.5 Other
  7. 4.2 Global Pharmaceutical Excipients Sales by Type
  8. 4.2.1 Global Pharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmaceutical Excipients Sales by Type (2021-2032)
  10. 4.2.3 Global Pharmaceutical Excipients Sales Market Share by Type (2021-2032)
  11. 4.3 Global Pharmaceutical Excipients Revenue by Type
  12. 4.3.1 Global Pharmaceutical Excipients Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pharmaceutical Excipients Revenue by Type (2021-2032)
  14. 4.3.3 Global Pharmaceutical Excipients Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Excipients Market by Application
  1. 5.1 Pharmaceutical Excipients Application Introduction
  2. 5.1.1 Formulation Stability Excipients
  3. 5.1.2 Solid Preparation Excipients
  4. 5.1.3 Semi-Solid Preparation Excipients
  5. 5.1.4 Liquid Preparation Excipients
  6. 5.1.5 Other
  7. 5.2 Global Pharmaceutical Excipients Sales by Application
  8. 5.2.1 Global Pharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pharmaceutical Excipients Sales by Application (2021-2032)
  10. 5.2.3 Global Pharmaceutical Excipients Sales Market Share by Application (2021-2032)
  11. 5.3 Global Pharmaceutical Excipients Revenue by Application
  12. 5.3.1 Global Pharmaceutical Excipients Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Pharmaceutical Excipients Revenue by Application (2021-2032)
  14. 5.3.3 Global Pharmaceutical Excipients Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Excipients Sales by Region
  1. 6.1 Global Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Excipients Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceutical Excipients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical Excipients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical Excipients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceutical Excipients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceutical Excipients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceutical Excipients Revenue by Region
  1. 7.1 Global Pharmaceutical Excipients Revenue by Region
  2. 7.1.1 Global Pharmaceutical Excipients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceutical Excipients Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceutical Excipients Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceutical Excipients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceutical Excipients Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceutical Excipients Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceutical Excipients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceutical Excipients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 DuPont (FMC)
  2. 8.1.1 DuPont (FMC) Company Information
  3. 8.1.2 DuPont (FMC) Business Overview
  4. 8.1.3 DuPont (FMC) Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DuPont (FMC) Pharmaceutical Excipients Product Portfolio
  6. 8.1.5 DuPont (FMC) Recent Developments
  7. 8.2 JRS Pharma
  8. 8.2.1 JRS Pharma Company Information
  9. 8.2.2 JRS Pharma Business Overview
  10. 8.2.3 JRS Pharma Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 JRS Pharma Pharmaceutical Excipients Product Portfolio
  12. 8.2.5 JRS Pharma Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BASF Pharmaceutical Excipients Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Lubrizol
  20. 8.4.1 Lubrizol Company Information
  21. 8.4.2 Lubrizol Business Overview
  22. 8.4.3 Lubrizol Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lubrizol Pharmaceutical Excipients Product Portfolio
  24. 8.4.5 Lubrizol Recent Developments
  25. 8.5 Ashland
  26. 8.5.1 Ashland Company Information
  27. 8.5.2 Ashland Business Overview
  28. 8.5.3 Ashland Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ashland Pharmaceutical Excipients Product Portfolio
  30. 8.5.5 Ashland Recent Developments
  31. 8.6 Croda International
  32. 8.6.1 Croda International Company Information
  33. 8.6.2 Croda International Business Overview
  34. 8.6.3 Croda International Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Croda International Pharmaceutical Excipients Product Portfolio
  36. 8.6.5 Croda International Recent Developments
  37. 8.7 Roquette
  38. 8.7.1 Roquette Company Information
  39. 8.7.2 Roquette Business Overview
  40. 8.7.3 Roquette Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roquette Pharmaceutical Excipients Product Portfolio
  42. 8.7.5 Roquette Recent Developments
  43. 8.8 Shin-Etsu
  44. 8.8.1 Shin-Etsu Company Information
  45. 8.8.2 Shin-Etsu Business Overview
  46. 8.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shin-Etsu Pharmaceutical Excipients Product Portfolio
  48. 8.8.5 Shin-Etsu Recent Developments
  49. 8.9 Evonik
  50. 8.9.1 Evonik Company Information
  51. 8.9.2 Evonik Business Overview
  52. 8.9.3 Evonik Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Evonik Pharmaceutical Excipients Product Portfolio
  54. 8.9.5 Evonik Recent Developments
  55. 8.10 Associated British Foods
  56. 8.10.1 Associated British Foods Company Information
  57. 8.10.2 Associated British Foods Business Overview
  58. 8.10.3 Associated British Foods Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Associated British Foods Pharmaceutical Excipients Product Portfolio
  60. 8.10.5 Associated British Foods Recent Developments
  61. 8.11 Hnerkang
  62. 8.11.1 Hnerkang Company Information
  63. 8.11.2 Hnerkang Business Overview
  64. 8.11.3 Hnerkang Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hnerkang Pharmaceutical Excipients Product Portfolio
  66. 8.11.5 Hnerkang Recent Developments
  67. 8.12 Anhui Sunhere Pharmaceutical Excipients
  68. 8.12.1 Anhui Sunhere Pharmaceutical Excipients Company Information
  69. 8.12.2 Anhui Sunhere Pharmaceutical Excipients Business Overview
  70. 8.12.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolio
  72. 8.12.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
  73. 8.13 Chase Sun
  74. 8.13.1 Chase Sun Company Information
  75. 8.13.2 Chase Sun Business Overview
  76. 8.13.3 Chase Sun Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chase Sun Pharmaceutical Excipients Product Portfolio
  78. 8.13.5 Chase Sun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Excipients Value Chain Analysis
  2. 9.1.1 Pharmaceutical Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Excipients Production Mode & Process
  6. 9.2 Pharmaceutical Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Excipients Distributors
  9. 9.2.3 Pharmaceutical Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst